Clinical Trial Update: A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 study evaluating oral EX039 for mild Alzheimer's disease, with the trial currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• EX039

Snippet

Sponsor: Excelsior | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING